Chen Y Cheng

Introduction

Chen Y Cheng, based in Edison, NJ, is an innovative inventor known for his contributions to pharmaceutical science. He has made a significant impact in the field with his focused research on selective agonists for neurotransmitter receptors.

Latest Patents

His most notable patent is the Triazolylmethyl-indole ethylamine bisulfate salt. This compound, which is the bisulfate salt of N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl)ethylamine, plays a critical role as a selective agonist of 5-HT1-like receptors. It has shown promise in the treatment of migraines and associated disorders, highlighting its potential therapeutic benefits.

Career Highlights

Chen Y Cheng is currently employed at Merck & Company, Inc., a leading global healthcare company. His work in the pharmaceutical sector emphasizes his commitment to advancing medical solutions and improving patient outcomes. With a patent portfolio encompassing innovative treatments, Cheng's career is a testament to the power of research and development in addressing complex health issues.

Collaborations

Throughout his career, Chen has collaborated with notable colleagues, including James A McCauley and Jennifer L Vandrilla. These partnerships foster a dynamic exchange of ideas and expertise, contributing to the effective development of groundbreaking therapies.

Conclusion

In summary, Chen Y Cheng stands out as a dedicated inventor whose work significantly contributes to the field of pharmaceuticals. His innovation in creating targeted treatments underscores the importance of research in healthcare, positioning him among notable inventors in the industry.